Logo

CODA Genomics, Viventia Expand Protein-Expression Collaboration

Dec 20, 2006
NEW YORK (GenomeWeb News) — Protein translation company CODA Genomics today said it has expanded an ongoing collaboration with the Canadian antibody developer Viventia Biotech.
 
Under the terms of the agreement, CODA will apply its protein translational engineering systems to “various antibody projects within Viventia,” CODA said.  
 
The Laguna Hills, Calif.-based company said its translational engineering platforms enable synthetic biology advances by “solving problems related to protein expression, activity and solubility.”
 
Financial terms of the agreement were not released.

Filed under

Proteomics & Protein Research
proteomics
Breaking News
The Scan

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.

Study Points to Benefits of Local Consolidative Therapy, Targeted Treatments in Cancer Care

In JCO Precision Oncology, researchers report that local consolidative therapy combined with molecularly targeted treatments could improve survival for some lung cancer patients.

Genetic Variants That Lower LDL Cholesterol Linked to Reduced Heart Disease Risk

Rare variants in two genes that lower LDL cholesterol are also associated with a decreased risk of coronary heart disease, according to a new JAMA Cardiology study.

Study Links Evolution of Longevity, Social Organization in Mammals

With the help of comparative phylogenetics and transcriptomics, researchers in Nature Communications see ties between lifespan and social organization in mammals.